Shots:   The EC approved 10 New Chemical Entities in April 2024, leading to treatments for patients and advances in the healthcare industry   In April 2024, the major highlighted drugs were Takeda’s Fruzaqla to treat Adults with mCRC and Johnson & Johnson’s Rybrevant for the treatment NSCLC  PharmaShots has compiled a list of 5 drugs that have received positive…